Agios Pharmaceuticals, Inc. (AGIO) Social Stream



Agios Pharmaceuticals, Inc. (AGIO): $25.45

2.09 (+8.95%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AGIO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Agios Pharmaceuticals Inc (AGIO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering AGIO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 8 $95 $50 $67 $31.42 113.24%
2021-11-18 8 $95 $42 $65.4 $31.42 108.15%
2021-12-14 9 $95 $42 $63.5 $31.42 102.1%
2022-02-01 8 $95 $42 $63.5 $31.42 102.1%
2022-02-08 8 $95 $32 $61.833 $31.42 96.8%
2022-02-22 8 $98 $30 $62.166 $31.42 97.85%
2022-02-24 8 $96 $30 $61.833 $31.42 96.8%
2022-03-01 8 $96 $30 $61.333 $31.42 95.2%
2022-03-03 7 $96 $30 $61.333 $31.42 95.2%
2022-03-08 7 $96 $30 $59.2 $31.42 88.42%

The Trend in the Analyst Price Target


Over the past 124 days, AGIO's average price target has gone down $6.83.

AGIO reports an average of 93.81% for its upside potential over the past 124 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-13 9 95 42 63.500 31.67 100.51%
2022-02-22 8 98 30 62.166 28.86 115.41%
2022-03-01 8 96 30 61.333 32.20 90.48%
2022-03-03 7 96 30 61.333 32.13 90.89%
2022-03-08 8 96 30 60.166 30.68 96.11%

AGIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.14 3 0 4 0 0 7

The Trend in the Broker Recommendations


Over the past 59 days, AGIO's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • Agios Pharmaceuticals Inc's variance in analysts' estimates is lower than -989.52% of all US stocks.
  • AGIO has a greater upside potential (average analyst target price relative to current price) than 939.74% of all US stocks.
  • In the context of Pharmaceutical Products stocks, Agios Pharmaceuticals Inc's average analyst price target is higher than 914.79% of them.
  • In terms of how Agios Pharmaceuticals Inc fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 817.67% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Agios Pharmaceuticals Inc are ADCT, ACAD, and XTNT.

Is AGIO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.492 seconds.